DE602005025332D1 - 4-ä2-(cycloalkylamino)pyrimidin-4-ylü-(phenyl)imidazolin-2-onderivate als inhibitoren der p38-map-kinase zur behandlung von entzündlichen krankheiten - Google Patents
4-ä2-(cycloalkylamino)pyrimidin-4-ylü-(phenyl)imidazolin-2-onderivate als inhibitoren der p38-map-kinase zur behandlung von entzündlichen krankheitenInfo
- Publication number
- DE602005025332D1 DE602005025332D1 DE602005025332T DE602005025332T DE602005025332D1 DE 602005025332 D1 DE602005025332 D1 DE 602005025332D1 DE 602005025332 T DE602005025332 T DE 602005025332T DE 602005025332 T DE602005025332 T DE 602005025332T DE 602005025332 D1 DE602005025332 D1 DE 602005025332D1
- Authority
- DE
- Germany
- Prior art keywords
- imidazolin
- map kinase
- ylü
- onderivate
- cycloalkylamino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004133204 | 2004-04-28 | ||
US56608904P | 2004-04-29 | 2004-04-29 | |
JP2005007832 | 2005-01-14 | ||
PCT/JP2005/008564 WO2005105790A1 (en) | 2004-04-28 | 2005-04-28 | 4- 2- (cycloalkylamino) pyrimidin-4-yl ! - (phenyl) - imidazolin-2- one derivatives as p38 map- kinase inhibitors for the treatment of inflammatory diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602005025332D1 true DE602005025332D1 (de) | 2011-01-27 |
Family
ID=43384198
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602005025332T Active DE602005025332D1 (de) | 2004-04-28 | 2005-04-28 | 4-ä2-(cycloalkylamino)pyrimidin-4-ylü-(phenyl)imidazolin-2-onderivate als inhibitoren der p38-map-kinase zur behandlung von entzündlichen krankheiten |
Country Status (12)
Country | Link |
---|---|
US (1) | US7700771B2 (de) |
EP (1) | EP1740578B1 (de) |
JP (1) | JP2007535476A (de) |
AT (1) | ATE491704T1 (de) |
AU (1) | AU2005238390C1 (de) |
BR (1) | BRPI0510335A (de) |
CA (1) | CA2563042C (de) |
DE (1) | DE602005025332D1 (de) |
MY (1) | MY143245A (de) |
NO (1) | NO20064175L (de) |
TW (1) | TWI326282B (de) |
WO (1) | WO2005105790A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100113481A1 (en) * | 2003-12-17 | 2010-05-06 | Alcon Research, Ltd. | Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents |
SI1928454T1 (sl) | 2005-05-10 | 2015-01-30 | Intermune, Inc. | Piridonski derivati za moduliranje s stresom aktiviranega protein kinaznega sistema |
EP1992344A1 (de) | 2007-05-18 | 2008-11-19 | Institut Curie | P38 Alpha als therapeutisches Target für Erkrankungen, die mit einer FGFR3- Mutation assoziiert sind |
JP5627574B2 (ja) | 2008-06-03 | 2014-11-19 | インターミューン, インコーポレイテッド | 炎症性および線維性疾患を治療するための化合物および方法 |
DE102009043260A1 (de) | 2009-09-28 | 2011-04-28 | Merck Patent Gmbh | Pyridinyl-imidazolonderivate |
DE102009049679A1 (de) | 2009-10-19 | 2011-04-21 | Merck Patent Gmbh | Pyrazolopyrimidinderivate |
DE102010049595A1 (de) | 2010-10-26 | 2012-04-26 | Merck Patent Gmbh | Chinazolinderivate |
EP2763993B1 (de) * | 2011-10-06 | 2017-04-19 | Bayer Intellectual Property GmbH | Heterocyclylpyri(mi)dinylpyrazol |
AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
KR102373700B1 (ko) | 2014-04-02 | 2022-03-11 | 인터뮨, 인크. | 항섬유성 피리디논 |
SI3762368T1 (sl) | 2018-03-08 | 2022-06-30 | Incyte Corporation | Aminopirazin diolne spojine kot zaviralci PI3K-y |
US11046658B2 (en) | 2018-07-02 | 2021-06-29 | Incyte Corporation | Aminopyrazine derivatives as PI3K-γ inhibitors |
US12084453B2 (en) | 2021-12-10 | 2024-09-10 | Incyte Corporation | Bicyclic amines as CDK12 inhibitors |
WO2024119067A1 (en) | 2022-12-02 | 2024-06-06 | Neumora Therapeutics, Inc. | Methods of treating neurological disorders |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL118544A (en) * | 1995-06-07 | 2001-08-08 | Smithkline Beecham Corp | History of imidazole, the process for their preparation and the pharmaceutical preparations containing them |
AR016294A1 (es) | 1997-07-02 | 2001-07-04 | Smithkline Beecham Corp | Compuesto de imidazol sustituido, composicion farmaceutica que la contiene, su uso en la fabricacion de un medicamento y procedimiento para supreparacion |
CA2316296A1 (en) * | 1997-10-10 | 1999-04-22 | Imperial College Of Science, Technology And Medicine | Use of csaidtm compounds for the management of uterine contractions |
CO5170501A1 (es) * | 1999-04-14 | 2002-06-27 | Novartis Ag | AZOLES SUSTITUIDOS UTILES PARA EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR TNFa eIL-1 Y ENFERMEDADES DEL METABOLISMO OSEO |
US6492516B1 (en) * | 1999-05-14 | 2002-12-10 | Merck & Co., Inc. | Compounds having cytokine inhibitory activity |
CN1222520C (zh) * | 1999-08-12 | 2005-10-12 | 沃泰克斯药物股份有限公司 | c-JUN N-末端激酶(JNK)和其它蛋白激酶的抑制剂 |
JP2003535062A (ja) * | 2000-06-01 | 2003-11-25 | メルク エンド カムパニー インコーポレーテッド | Jnk阻害剤としての(二置換フェニル)ピリミジニルイミダゾール誘導体の使用 |
PE20020506A1 (es) * | 2000-08-22 | 2002-07-09 | Glaxo Group Ltd | Derivados de pirazol fusionados como inhibidores de la proteina cinasa |
MXPA04003729A (es) * | 2001-10-22 | 2004-07-23 | Tanabe Seiyaku Co | Compuestos de 4-imidazolin-2-ona. |
AU2003237446A1 (en) * | 2002-06-05 | 2003-12-22 | Pharmacia Corporation | Pyrazole-derivatives as p38 kinase inhibitors |
US7119421B2 (en) | 2002-06-06 | 2006-10-10 | Koninklijke Philips Electronics N.V. | Quad flat non-leaded package comprising a semiconductor device |
EP1633758B1 (de) * | 2003-05-15 | 2011-11-23 | Arqule, Inc. | Imidazothiazole und imidazoxazolderivative als inhibitoren von p38 |
-
2005
- 2005-04-27 MY MYPI20051847A patent/MY143245A/en unknown
- 2005-04-27 TW TW094113384A patent/TWI326282B/zh not_active IP Right Cessation
- 2005-04-28 JP JP2006519531A patent/JP2007535476A/ja not_active Ceased
- 2005-04-28 AU AU2005238390A patent/AU2005238390C1/en not_active Ceased
- 2005-04-28 CA CA2563042A patent/CA2563042C/en not_active Expired - Fee Related
- 2005-04-28 US US11/587,498 patent/US7700771B2/en not_active Expired - Fee Related
- 2005-04-28 DE DE602005025332T patent/DE602005025332D1/de active Active
- 2005-04-28 BR BRPI0510335-5A patent/BRPI0510335A/pt not_active IP Right Cessation
- 2005-04-28 WO PCT/JP2005/008564 patent/WO2005105790A1/en active Application Filing
- 2005-04-28 EP EP05738662A patent/EP1740578B1/de not_active Not-in-force
- 2005-04-28 AT AT05738662T patent/ATE491704T1/de not_active IP Right Cessation
-
2006
- 2006-09-15 NO NO20064175A patent/NO20064175L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ATE491704T1 (de) | 2011-01-15 |
TWI326282B (en) | 2010-06-21 |
WO2005105790A1 (en) | 2005-11-10 |
MY143245A (en) | 2011-04-15 |
EP1740578B1 (de) | 2010-12-15 |
US7700771B2 (en) | 2010-04-20 |
TW200536843A (en) | 2005-11-16 |
JP2007535476A (ja) | 2007-12-06 |
BRPI0510335A (pt) | 2007-10-23 |
EP1740578A1 (de) | 2007-01-10 |
US20070185326A1 (en) | 2007-08-09 |
AU2005238390B2 (en) | 2009-01-08 |
CA2563042A1 (en) | 2005-11-10 |
CA2563042C (en) | 2010-04-27 |
NO20064175L (no) | 2006-12-13 |
AU2005238390C1 (en) | 2009-06-25 |
AU2005238390A1 (en) | 2005-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602005025332D1 (de) | 4-ä2-(cycloalkylamino)pyrimidin-4-ylü-(phenyl)imidazolin-2-onderivate als inhibitoren der p38-map-kinase zur behandlung von entzündlichen krankheiten | |
EA200870358A1 (ru) | 2-(циклический амино) пиримидоновые производные в качестве ингибиторов tpk1 | |
EA200701257A1 (ru) | Пирролопиразолы в качестве сильнодействующих ингибиторов киназы | |
JO2791B1 (en) | Acid secretion inhibitor | |
TW200633991A (en) | Chemical compounds | |
ATE479667T1 (de) | Als kinaseinhibitoren geeignete verbindungen auf thiazolylbasis | |
DE602005009209D1 (de) | Zur behandlung von entzündungen geeignete indole | |
TW200740820A (en) | Fused heterocyclic derivatives and use thereof | |
AR053662A1 (es) | Compuestos de pirazol inhibidores de la actividad quinasa cdk y gsk | |
BRPI0506817A (pt) | inibidores seletivos de quinase | |
NO20072605L (no) | Nytt antranilinsyrederivat eller et salt derav | |
EA200601852A1 (ru) | Тетрагидрохинолиновые производные и способ их получения | |
NO20080761L (no) | Acykliske Ikur inhibitorer | |
EA200601358A1 (ru) | Новые ингибиторы химазы | |
EA200700141A1 (ru) | Новые аминоциклические производные мочевины, их получение и фармацевтическое применение в качестве ингибиторов киназы | |
UA83243C2 (ru) | Соединения, которые ингибируют натриезависимый переносчик глюкозы | |
WO2007016392A3 (en) | Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors | |
NO20065537L (no) | Heterosykliske amidforbindelser og anvendelse derav som en MMP-13-inhibitor | |
UA117151C2 (uk) | N-ациліміногетероциклічні сполуки | |
ATE553077T1 (de) | Peptidaseinhibitoren | |
ATE543803T1 (de) | 3-ä2-(3-azylamino-2-oxo-2h-pyridin-1- yl)acetylaminoü-4-oxopentansäurederivate und deren verwendung als caspase-inhibitoren | |
PE20020524A1 (es) | 7-oxo-piridopirimidinas como inhibidores de quinasas | |
CO5680420A2 (es) | Compuestos de 6-amino-1h-indazol y 4-aminobenzenofurano como inhibidores de la fosfodiesterasa 4 | |
DE502006008710D1 (de) | Substituierte tetrahydroisochinoline als mmp-inhibitoren, verfahren zu ihrer herstellung und ihre verwendung als medikament | |
TW200616997A (en) | The preparation method for 6-substituted-1-methyl-1h-benzoimidazol derivatives and their preparation imtermediates |